Gavin Newsom Underestimated Deadline for Bold Insulin Plan by Years
Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
The Associated Press on MSN15d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
Beta Bionics targets $114M IPO raise to fund insulin pump development
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
devdiscourse2d
From Drug Approvals to Global Health Funding: Key Updates in Health Sector
This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
KHOU 119d
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
The Courier-Journal6d
Will cost of insulin rise after Trump's executive action on healthcare? What we know
An executive order signed by former President Joe Biden aimed at lowering prescription drug prices was among those voided by President Donald Trump's flurry of executive orders this week.
Newsweek15d
Gavin Newsom Underestimated Deadline for Bold Insulin Plan by Years
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...